Plunkett Research Online: Summit Therapeutics

SUMMIT THERAPEUTICS (SMMT:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Summit Therapeutics PLC is a biopharmaceutical company. It is involved in the business of discovery, development, and commercialization of medicines for indications for which there inadequate or no therapies. It also conducts clinical programs focused on the genetic disease Cuchenne muscular dystroh.....



Summit Therapeutics
Ticker: SMMT
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 44 1235443939
Fax: 44 1235443999
Address: 136a Eastern Avenue
Milton Park
Abingdon, Oxfordshire OX14 4SB United Kingdom

Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
ContactsDescription
Erik OstrowskiCFO
Barry PriceDirector
See More
Summit Therapeutics PLC is a biopharmaceutical company. It is involved in the business of discovery, development, and commercialization of medicines for indications for which there inadequate or no therapies. It also conducts clinical programs focused on the genetic disease Cuchenne muscular dystroh.....See More See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor: Druces LLP
$USD, In whole numbers,
except marked * or %
201820172016201520142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (GBP)Bonus (GBP)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: